SCHEMBL4765666

SCHEMBL4765666

CCOC(=O)c1c[nH]c2c(O)c(F)c(C3CC3)cc2c1=O

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C19 P33261 1/20 0.55
CLEC4M Q9H2X3 1/20 0.50
KDM4E B2RXH2 3/20 0.47
MAPT P10636 2/20 0.47
GABRA1 P14867 3/20 0.46
GABRB2 P47870 3/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
GABRB1 P18505 2/20 0.45
GABRA3 P34903 2/20 0.45
ALDH1A1 P00352 2/20 0.41
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4723533 0.87 CYP1A2 (0.53) CYP1A2CYP3A4CYP2C19CLEC4MKDM4E
SCHEMBL30540821 0.84 CYP1A2 (0.62) CYP1A2CYP3A4CYP2C19CLEC4MKDM4E
SCHEMBL19971590 0.84 CYP1A2 (0.62) CYP1A2CYP3A4CYP2C19CLEC4MKDM4E
SCHEMBL4721467 0.83 KDM4E (0.43) CYP1A2KDM4EMAPTKMT2AMEN1
SCHEMBL9487698 0.81 CYP1A2 (0.56) CYP1A2CYP3A4CYP2C19CLEC4MKDM4E
SCHEMBL7025537 0.81 CYP1A2 (0.56) CYP1A2CYP3A4CYP2C19CLEC4MKDM4E
SCHEMBL7509482 0.79 CYP1A2 (0.53) CYP1A2CYP3A4CYP2C19CLEC4MKDM4E
SCHEMBL7509600 0.78 CYP1A2 (0.49) CYP1A2CYP3A4CYP2C19CLEC4MKDM4E
SCHEMBL9635290 0.78 CYP1A2 (0.66) CYP1A2CYP3A4CYP2C19CLEC4MKDM4E
SCHEMBL29376920 0.78 CYP1A2 (0.66) CYP1A2CYP3A4CYP2C19CLEC4MKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1931684-A2 OXAZOLIDINONE-QUINOLONE HYBRIDS AS ANTIBACTERIAL COMPOUNDS Actelion Pharmaceuticals Ltd. (CH) 2008-06-18 EP disclosed
WO-2007017828-A2 OXAZOLIDINONE-QUINOLONE HYBRIDS AS ANTIBACTERIAL COMPOUNDS ACTELION PHARMACEUTICALS LTD (CH) 2007-02-15 WO disclosed